Richard Douglas, Director at Aldeyra Therapeutics, Inc. (ALDX), bought 20,000 shares at $5.75 ($118K) on 2019-09-11, disclosed to the SEC on 2019-09-13.
Open-market purchase of $118k ALDX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.75 | 10,000 | $58K | 48.8% |
| 2 | $6.03 | 10,000 | $60K | 51.2% |
| Total | $5.89 avg | 20,000 | $118K | 100% |
| Filing → |
| MXCT | BUY | 2023-03-30 | $346K | — | Filing → |
| MXCT | BUY | 2021-11-23 | $445K | — | Filing → |
| ALDX | BUY | 2020-03-17 | $110K | — | Filing → |